ELISA Kit for Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
Size
1Catalog no#
SEA139RaPrice
834 EURAssay length
3h
Tissue
tumor
Detection range
0.156-10ng/mL
Organism species
Rattus norvegicus (Rat)
Method
Double-antibody Sandwich
Research Area
Apoptosis;Tumor immunity;
Format
48T, 96T, 96T×5, 96T×10, 96T×100
Item Name
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
Application
Enzyme-linked immunosorbent assay for Antigen Detection.
Test
ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED
Sensitivity
The minimum detectable dose of this kit is typically less than 0.054ng/mL
Sample type
Serum, plasma, tissue homogenates, cell lysates and other biological fluids.
Alternative Names
CD253; TNFSF10; APO2L; Apo2-L; TL2; TRAIL; Tumor Necrosis Factor Ligand Superfamily Member 10; Apo-2 Ligand
Properties
E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Description
This 1 is suited for programmed cell-death studies.Aplha, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation. Complex subunit associated factors are involved in hybridoma growth, Eosinohils, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex. NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells.FAS ligand and other ligands are binding to the receptor for signaling pathways for example in apoptosis or JNK signaling. Receptor agonists are often tested for drug development.